Posts

, ,

Efforts to Prevent the Spread of Diseases

Prevent the Spread of Diseases
The recent global health crisis, triggered by the onset of the COVID-19 pandemic, has brought to the forefront the importance of efforts to prevent the spread of diseases. While treatment is crucial, proactive steps to reduce the risk of disease transmission are equally important. Disease prevention plays a critical role in promoting public health, especially in low- and middle-income countries.

Gavi’s Work to Prevent the Spread of Diseases

Gavi, the Vaccine Alliance, is a public-private partnership that is committed to improving access to life-saving vaccines in low-income countries with the aim to prevent the spread of diseases. The partnership has played a critical role in reducing the incidence of vaccine-preventable diseases worldwide by providing funding, technical support and vaccines to increase access to immunization programs in the world’s poorest countries.

Gavi has assisted in the vaccination of more than 981 million children, which will prevent at least 16.2 million disease-related child mortalities at minimum. Its efforts have also resulted in the successful introduction of new vaccines in low-income countries, including the pneumococcal and rotavirus vaccines.

The Global Fund’s Efforts

The Global Fund to Fight AIDS, Tuberculosis and Malaria is another public-private partnership committed to reducing the incidence of these three deadly diseases, increasing access to treatment and care and improving health outcomes in low- and middle-income countries. It has played a critical role in preventing the spread of diseases such as HIV/AIDS by providing funding to support HIV prevention, testing, treatment and care services.

In 2021 alone, the Global Fund provided HIV-preventative services to 12.5 million at-risk individuals and helped to provide about 670,000 HIV-positive mothers with treatment to sustain themselves and prevent mother-to-child HIV transmission. These efforts have led to a significant reduction in HIV/AIDS-related deaths worldwide.

The Global Fund has also played a crucial role in expanding access to TB prevention, diagnosis and treatment services, contributing to a decline in TB-related deaths worldwide. In addition, the Global Fund has supported the distribution of insecticide-treated mosquito nets, indoor spraying and other preventative measures to reduce the incidence of malaria, resulting in a significant reduction in malaria-related deaths worldwide.

Positive Impacts

The impact of these global health initiatives in preventing the spread of diseases worldwide is reflected in the significant progress made in reducing the incidence of HIV/AIDS, TB and malaria. These partnerships have saved more than 50 million lives and significantly reduced the number of new infections and deaths linked to HIV/AIDS, tuberculosis and malaria.

Contributions to the fight against these deadly diseases have not only significantly reduced the number of new infections and deaths but also strengthened the health systems of low and middle-income countries to better cope with disease outbreaks and other public health emergencies.

Prevention is Key

Disease transmission is a significant public health challenge, with prevention being the key, and everyone from individuals to communities and governments has an important role to play in proactively addressing the issue.

Practicing good hygiene, obtaining vaccinations and accessing health care for the early detection and treatment of illnesses are all essential strategies in preventing the spread of disease. Good hygiene, such as hand washing and avoiding contact with sick individuals, is a basic yet effective way to reduce the risk of infection. Vaccination is critical in building immunity against various diseases and protecting vulnerable populations. Early detection and treatment of illnesses can reduce the severity of the illness and the risk of transmission to others.

It is also important to ensure that vulnerable and marginalized communities have access to prevention, treatment and care services. Strengthening the leadership, engagement and capacity of community-led organizations and networks can improve service continuity between community-led activities and formal health care provision. The Global Fund’s Community Engagement Strategic Initiative and community-led monitoring efforts work toward achieving these goals.

In conclusion, investing in preventative measures and global partnerships is critical in reducing the incidence of preventable diseases and saving lives.

– Nkechi First
Photo: Flickr

, ,

Tackling Child Poverty in Mali

Child Poverty in Mali
With a population of more than 21.6 million people, the average Malian woman gives birth to 5.7 children in her lifetime, according to World Bank data from 2020. Children between the ages of 0 and 14 accounted for 47% of the population in Mali in 2020. Because children stand as Mali’s future leaders and changemakers, it is important to address child poverty in Mali. According to the World Bank, in 2016, 41% of Malian children aged 0-17 lived in multidimensional poverty.

The United Nations describes child poverty as multi-faceted. According to this definition, child poverty involves deprivations of “nutrition, water and sanitation facilities, access to basic health care services, shelter,
[and] education.” While poverty hurts every group of people, regardless of age, poverty disproportionately impacts children as it affects children’s ability “to reach their full potential and to participate as full members of the society.”

Poor health care, inadequate nutrition, inaccessible education and nationwide conflict impact the well-being of children in Mali.

Child poverty remains a global crisis because childhood is a consequential stage of a person’s life. During childhood, the availability of basic resources such as access to good health care services, education, shelter, food and clean water determines the ability to survive, develop and thrive.

Facets of Child Poverty in Mali

  • Health. The poor health care system in Mali, especially in rural areas, affects children more than adults as preventable and treatable diseases such as malaria, measles, polio and diarrhea, pose serious threats to children living in poverty. Yet, “only 45[%]of children in Mali receive all basic vaccinations and 14[%]receive no vaccination at all, depriving them [of] protection from common childhood illnesses,” UNICEF reports. The lack of childhood vaccinations contributes to one in every 10 Malian children dying before reaching their fifth year of life. Inadequate health care also contributed to one of out every 30 newborn babies dying within the first month. UNICEF works with the Ministry of Health and Social Affairs, Gavi and the World Health Organization to “provide critical vaccines for children, improve routine vaccination and support complementary vaccination.” UNICEF has led vaccination efforts in Mali, ensuring 387,422 children receive vaccinations against measles in 2022.
  • Nutrition. In Mali, undernutrition is responsible for almost 50% of deaths among children under 5. The acute malnutrition rate in Mali is one of the highest in the world. In 2018, 27% of children under the age of 5 had stunted growth (low height-for-age) and 9% suffered wasting (low weight-for-height), according to USAID data. However, as of September 2022, 94,681 children aged between 6-59 months with Severe Acute Malnutrition (SAM) received treatment through the help of UNICEF.
  • Education. The shortage of trained teachers, lack of easily accessible schools, the prevalence of child marriage and conflict and insecurity across Mali contribute to poor education and child poverty in Mali. In the past 10 years, education in Mali has progressed, but more than 2 million Malian children between 5 and 17 still do not attend school. Furthermore, UNICEF reports that more than 50% of Mali’s youth aged 15 to 24 are illiterate. To tackle this, UNICEF and partners support the Government of Mali in providing out-of-school children with formal and informal education to enable them to reach their full potential. As of September 2022, slightly more than 16,000 Malian children can now access formal and non-formal education services, “including early learning,” and 19,939 children are benefiting from “individual learning materials.”
  • Conflicts. Ongoing violence and conflict impact children the most. Children miss out on education, risk displacement, exploitation and abuse and are unable to access essential services. Conflict and instability as well as funding shortages have led to the shutdowns of 1,700 schools in Mali as of March 2022. The European Union has given Mali more than €446 million worth of humanitarian aid since 2012. These funds go toward the provision of food, emergency shelter, access to health care services, protection and psychosocial services as well as children’s education.

The action of various groups helps to tackle the issue of child poverty in Mali. Through continued efforts, the international community can safeguard the rights of children in Mali.

– Oluwagbohunmi Bajela
Photo: Flickr

, , , , , ,

Global Developments in the Fight Against Malaria

Fight Against Malaria
According to the World Health Organization (WHO) in 2019, malaria infections stood at almost 230 million globally. Of these malaria incidents, 409,000 cases led to fatalities. These are the striking and often overlooked numbers encasing the global fight against malaria. Malaria, a parasitic infection that mosquito varieties ruthlessly spread, is an ancient disease plaguing regions across the globe, particularly within the warmer climates of the tropical and subtropical areas of the world.

The cyclical nature of the disease from uninfected mosquitoes to infected hosts then infected mosquitoes to uninfected hosts, is in part the reason this disease is difficult to counteract outside of preventive measures, such as traditional nets, drugs and various forms of insecticides. However, these methods have limitations. The insidious nature of repeat infections adds insult to injury, with reports indicating up to six malaria infections annually among some children. Now, the dawn of a malaria vaccine hopes to make strides in the fight against malaria.

The Dawn of a Malaria Vaccine

The daunting reality and statistics on malaria illustrate only one side of the story on emerging aid over the last three decades. After years of research and trials by the manufacturer, on October 6, 2021, WHO officially authorized the widespread use of a malaria vaccine that GlaxoSmithKline created called Mosquirix. This is not only a win in the fight against malaria. Mosquirix is “also the first vaccine ever recommended for use by WHO to combat a parasitic disease in humans.”

Dr. Pedro Alonso, director of WHO’s global malaria program, says in a press release that “[i]t’s a huge jump from the science perspective to have a first-generation vaccine against a human parasite.” The vaccine, which targets children, has the potential to prevent “23,000 deaths in children younger than 5 each year.” As it stands, the vaccine manufacturer has “committed to producing 15 million doses of Mosquirix annually” until 2028.

Development in Tandem With the Global Health Order

This trend toward vaccination campaigns, development and authorization does not of course appear in a vacuum. After decades of stalling efforts on malaria prevention, a new global health order has ushered in a recent admiration for the efficacy of vaccine funding, research and implementation on the back of the global struggle against COVID-19. Organizations championing the global vaccine battle against COVID-19, such as GAVI, the Vaccine Alliance, “likely play a crucial role in negotiating the financing, procurement and delivery of” the Mosquirix vaccine.

Other major players in the fight against COVID-19 are also entering the ring. BioNTech recently launched a malaria project in July 2021. Its intentions are the use of mRNA technology, which has proven highly effective in COVID-19 vaccines, in the fight against the malaria parasite. Clinical trials of the world’s “first mRNA-based vaccine for malaria prevention” will begin at the close of 2022. These new multilateral and multi-agency relationships in health care, which the pandemic brought about, could be the stepping stones for future breakthroughs in global health.

Looking Ahead

Spurred on by new movements in global health, the malaria vaccine will make strides within infant and youth populations across at-risk regions like Africa and beyond. Mosquirix pilot programs in Kenya, Malawi and Ghana “found that the vaccine is safe. There is community demand for it and it is a cost-effective prevention method.” While perhaps not intrinsically linked to the new global health order, the world is making strides in combating an ancient and sometimes overlooked disease through emerging technologies, monetary funding and intellectual endorsements. It is safe to say that the new malaria vaccine could set new precedents as to the way the world cooperates on matters of global health security so that the international community can develop long-lasting strategies to keep at-risk regions safe, productive and healthy.

– Aidan Swayne
Photo: Flickr

, , , ,

COVID-19 Vaccination in Qatar

COVID-19 Vaccination in Qatar
Located on the waters of the Persian Gulf, Qatar has an estimated COVID-19 vaccination rate of about 87%, administering more than 4.9 million doses to its people. It is a population percentage much higher than a number of other countries, including the United States, where just 59% of U.S. citizens are fully vaccinated.

Statistics

Qatar has fewer than 2.5 million inhabitants, more comparable to U.S. states like New Mexico or Kansas. Additionally, it seems that a higher vaccination rate has made a difference when it comes to the Middle Eastern country’s efforts to fight COVID-19. Cases are currently at around 8% of what Qatar had during its time of peak infections, dating back to May 2020 when there were a reported 2,300 new infections each day.

According to Qatar’s government communications office, the country has reported some 150 new coronavirus cases by late November 2021, with more than 100 of those afflicted ultimately recovering. Since the start of the pandemic, Qatar has reported a total of 242,000 cases, with 239,000 recoveries and 611 deaths.

Qatar’s infection rate has climbed a bit in recent weeks. Additionally, while the country’s efforts are better than some of its neighbors, like Yemen — which had climbed to 11% of its peak before dropping again — Qatar is behind others, including Bahrain, Saudi Arabia, Oman and the United Arab Emirates, which reported between 1% and 2% of their respective peaks.

Bahrain, for example, averages a little more than 20 new infections per day in a recent week, with 87% of the country completely vaccinated. Saudi Arabia has more than 35 new infections each day with 69% fully vaccinated. Oman is averaging about seven new infections daily with a 59% vaccination rate.

The UAE reported just fewer than 80 new infections each day with a vaccination rate of more than 100%. Yet, Yemen has kept its numbers mostly under control — reporting a half-dozen new infections each day despite just a little more than 1% of its population being fully vaccinated.

Precautions

The U.S. has shared with those living or visiting Qatar the precautions the country has implemented since July 2020 to help limit the spread of the coronavirus there. That includes a little bit of technology — a smartphone app called Ehteraz used for contact tracing.

The country also limits the number of people allowed in cars, and how far athletes can travel to participate in sports. Of course, there are requirements for face masks and social distancing. Anyone not abiding by these rules faces stiff fines and potential jail time.

Qatar is currently in what it describes as its fourth phase of reopening, allowing some gatherings and small groups, and the elimination of masks in open public places, except where otherwise required — like in organized public events, schools and mosques.

Currently, the State Department has a travel heath advisory of Level 3 due to the number of COVID-19 cases in the country. It advises anyone entering the country to be fully vaccinated.

Vaccine Distribution

Despite what appears to be high COVID-19 vaccination rates in Qatar, a study published in the National Library of Medicine in May 2021 suggests about 20% of the country’s population does not want the coronavirus vaccine. Surveys occurred in November 2020, before vaccines had received government approvals in many countries, including the United States, and when people were still building knowledge about the safety of the vaccine. The survey involved more than 7,800 adults.

Since then, Qatar has approved the Pfizer vaccine for emergency use and is available to everyone for free. However, the Qatari government recommends those at higher risk — such as the elderly, those with chronic medical conditions, as well as health care workers — are first in line.

COVID-19’s Impact on Qatar’s Economy and People

The effects of COVID-19 have, for obvious reasons, reduced worldwide travel. This has led to OPEC reporting its lowest demand for oil in 30 years. The heaviest impacted sectors of Qatari society include manufacturing, real estate and transportation. Finance and construction also have experienced a moderate impact on Qatar’s expected gross domestic product, according to KPMG International.

How Qatar is Doing its Part

During the Global Vaccine Summit in June 2020, when the coronavirus pandemic was at its worst, Qatar pledged the equivalent of $20 million in U.S. currency to GAVI. GAVI is an international vaccine organization that intends to help underserved countries in the world through the global COVAX initiative.

The money Qatar donated was double its earlier pledge of $10 million that lasted from 2016-2020. The money from 2016-2020 went directly to GAVI with no funding for COVAX. GAVI will distribute the money evenly with $10 million going to funding GAVI’s core programs from 2021-2025 and the other $10 million will help finance the COVAX AMC initiative10.

COVID-19 vaccination in Qatar is at remarkably high levels. The vaccine and other measures still in place in the country have dramatically reduced the number of active and new coronavirus cases in the country to a fraction of their peaks in the summer of 2020.

– Julian Smith
Photo: Unsplash

, , , ,

COVAX Helps Pakistan’s Vaccination Campaign

Pakistan’s vaccination campaignOn July 17, 2021, COVAX gave 1.2 million doses of the AstraZeneca COVID-19 vaccine to Islamabad, Pakistan. These doses are an addition to five million COVID-19 vaccines already delivered to Pakistan by COVAX. By July 17, 2021, Pakistan had fully vaccinated 4.5 million people and partially vaccinated 18 million people. The new batch of vaccines will assist the government of Pakistan’s vaccination campaign, which started in February 2021.

The COVAX Initiative

COVAX, an international coalition led by Gavi, the Vaccine Alliance, WHO, CEPI and UNICEF, aims to ensure equitable access to COVID-19 vaccines. These organizations have teamed up with manufacturers to secure COVID-19 vaccine doses as well as manage the “freight, logistics and storage” of the vaccines.

Through COVAX, vaccines will be delivered to “92 low- and lower-middle-income countries” as well as “more than 97 upper-middle-income and high-income nations.” With these vaccine equity efforts, COVAX aids more than 80% of the global population. So far, COVAX has assisted Pakistan’s vaccination campaign by supplying 2.4 million doses of AstraZeneca, roughly 100,000 doses of Pfizer and 2.5 million Moderna vaccines to Pakistan.

COVID-19 in Pakistan

Pakistan was seeing slow economic improvement prior to the pandemic with yearly per capita growth averaging just 2%. Since the onset of COVID-19, Pakistan has now surpassed one million COVID-19 cases with more than 24,000 deaths. Furthermore, COVID-19’s impacts have left about 50% of the working class jobless and many of those who retained employment saw their income decrease. Informal and lower-skilled employees were the most impacted by unemployment. Like many countries, poverty has risen in Pakistan, with more than two million people pushed under the international poverty line in 2020. According to the World Bank, poverty incidence increased from 4.4% to 5.4% in the 2020 fiscal year.

Pakistan’s Vaccination Campaign

In the months following the lift of lockdowns in May 2020, Pakistan’s economy had been slowly recovering as the industry and service sectors became more active and production increased. Pakistan’s vaccination campaign is essential to stop the spread of COVID-19 and continue economic progress.

The World Health Organization’s Pakistan representative, Dr. Palitha Mahipala, praised the country’s vaccination campaign. She described the reach of the vaccination effort as a “remarkable achievement.” According to Dr. Mahipala, Pakistan distributes COVID-19 vaccines equitably, reaching citizens in even the most remote areas of Pakistan. Another UNICEF Pakistan representative, Aida Girma, says that the latest delivery of 1.2 million doses comes at a “critical time” as the Pakistani government aims to significantly boost its vaccination campaign to reach a greater portion of the population.

Looking to the Future

According to the World Bank, “the global economy is expected to expand 4% in 2021, assuming an initial COVID-19 vaccine rollout becomes widespread throughout the year.” Furthermore, according to the World Economic Forum, equitable access to COVID-19 vaccines means “10 major economies could be $466 billion better off by 2025.” These projections show that COVID-19 vaccination campaigns support economic recovery, nationally and internationally. With further support, there is hope for the full vaccination of Pakistan’s population in the near future, which will help boost the country’s recovering economy, contributing to overall global economic recovery.

– Gene Kang
Photo: Wikimedia Commons

, , , ,

Ngozi Okonjo-Iweala on Ending Poverty

W.T.O Director-General Ngozi Okonjo-Iweala On Ending Poverty
On March 1, 2021, Ngozi Okonjo-Iweala took office as the director-general of the World Trade Organization (WTO). She is the first woman and the first African to hold this office. After experiencing the Nigerian Civil War, she came to the U.S. and studied development economics at Harvard University. She also received her doctorate in regional economics and development from the Massachusetts Institute of Technology. In 2003, she served as Nigeria’s finance minister. After a second appointment ending in 2015, she also served as a foreign minister and worked for the World Bank for 25 years, overseeing an $81 billion portfolio. In her newly appointed role, Okonjo-Iweala promises to influence and implement policy in order to restore the global economy.

What is the World Trade Organization?

The World Trade Organization is an international organization that deals with the “rules of trade between nations.” Member governments negotiate trade agreements that are then ratified in their own parliaments. All major decisions are made by the membership as a whole, either by ministers, their ambassadors or delegates.

The WTO plays an important role in reducing global poverty. Studies show that free trade helps impoverished countries “catch up with” developed nations. More than three-quarters of WTO members are developing countries. Every WTO agreement holds particular provisions for these countries, including longer time spans to carry out agreed-upon policies, “measures to increase their trading opportunities” and assistance to support these countries in building the necessary infrastructure to improve their economies. Least-developed countries are often exempt from many provisions.

The WTO also aims to reduce living costs and improve living standards by mitigating the effect of protectionism on consumer costs. This means that products are more affordable for those with a lower income. In addition, lowering such trade barriers stimulates economic growth and employment, creating opportunities for the impoverished to increase their incomes.

Okonjo-Iweala and Poverty

Okonjo-Iweala’s long list of achievements includes many in the realm of poverty reduction. As the minister of finance in Nigeria, she helped Africa’s largest economy “grow an average of 6% a year over three years.” She also helped create “reform programs that improved governmental transparency and stabilizing the economy.”

As the board chair of Gavi, the Vaccine Alliance, she contributed to ensuring vaccine equity. During her 25-year career at the World Bank, she rose to the second-most prominent position of managing director. Okonjo-Iweala ran for the office of director-general of the WTO with the strong belief that trade has the power to lift people out of poverty.

Okonjo-Iweala is also a supporter of COVAX, aiming to resolve vaccine nationalism. During the COVID-19 pandemic, vaccine nationalism is a problem that disproportionately affects impoverished countries. COVAX is a global vaccination effort launched by Gavi and leading partners to ensure vaccine equity.

In a January 2021 article, Okonjo-Iweala writes that “All manufacturers must step up and make their vaccines available and affordable to COVAX,” in order to ensure equitable and timely vaccine distribution to low-income countries. She also warned against repeating history.

In 2009, a small number of high-income countries bought up most of the global supply of the H1N1 flu vaccine, which left the rest of the world lacking. If history were to repeat itself during the COVID-19 pandemic, the impact on impoverished countries, and the world at large, would be devastating.

Okonjo-Iweala’s Plan

As director-general of the WTO, Okonjo-Iweala’s immediate plans focus on ending the COVID-19 pandemic with vaccines for all. In a statement outlining her vision for the future of the WTO, she says “the WTO can and must play a more forceful role in exercising its monitoring function and encouraging Members to minimize or remove export restrictions and prohibition that hinder supply chains for medical goods and equipment.”

She also says that member nations of the WTO need to adopt a stronger stance in preventing vaccine nationalism and protectionism. International cooperation, in her opinion, is the only way to come up with the vaccines, therapeutics and diagnostics needed to put an end to the COVID-19 pandemic.

Okonjo-Iweala has promised to face the economic and health challenges presented by the novel coronavirus head-on. Importantly, she notes that “a strong WTO is vital if we are to recover fully and rapidly from the devastation wrought by the COVID-19 pandemic.” Okonjo-Iweala promises to work in a collaborative effort to “shape and implement the policy responses” necessary to restore the global economy.

– Brooklyn Quallen
Photo: Flickr

, , ,

The Impact of COVID-19 on Poverty in Ghana

impact of COVID-19 on poverty in Ghana
Ghana’s poverty rate has halved over the past 20 years, but COVID-19 stunted the country’s progress. Amid an economic crisis, many Ghanaian people have lost their jobs, healthcare and education due to the pandemic. The impact of COVID-19 on poverty in Ghana is severe, especially for women and children.

Child Labor is on the Rise

Global child labor decreased by nearly 40% between 2000 and 2020, but COVID-19 forced many children into the workforce. Before the pandemic started, 160 million children participated in child labor. If countries cannot mitigate the economic impacts of COVID-19, around 168.9 million children could be in child labor by the end of 2022. Children in low-income countries like Ghana are particularly at risk of experiencing child labor. Between expansive school closures, increased unemployment and lost family members due to COVID-19, Ghanaian children have become more susceptible to child labor since the pandemic started.

Children and families often turn to child labor because it is the only option available to meet their basic needs. Ghanaian children as young as 8 years old work jobs in industries such as mining, carpentry, fishing and transporting goods to support themselves and their families. Most countries have developed economic relief packages to assist families who are struggling, but it can be challenging for low-income countries to afford adequate social protection programs. The World Bank found that low-income countries, on average, spend only about $6 per capita in response to the pandemic. Adequate social protection programs may be necessary to fully combat the impact of COVID-19 on poverty in Ghana.

Educational Opportunities are Sparse

Many Ghanaian children have lost their educations since the pandemic started because of school closures or the need to drop out and support their families. At a shortage of proper funding, schools in Ghana struggle to afford food, technology for remote learning and resources for students with disabilities. Food insecurity has increased for students who formerly relied on their schools to provide meals every day. According to a recent study by Innovations for Poverty Action, 72% of Ghanaian children in public schools did not receive their usual daily lunches and 30% said they experienced hunger as a result of their schools closing. Without access to education, Ghanaian children are at risk of hunger and exploitation due to the vast impact of COVID-19 on poverty in Ghana.

To combat malnutrition, UNICEF is providing children with micronutrient supplements, such as iron folate, to improve children’s health. The Girls Iron Folate Tablet Supplementation (GIFTS) Programme, which UNICEF helped the Ghana Health Service implement and develop, has reduced anemia in girls from the Northern and Volta Regions of Ghana by 26%. UNICEF is also helping Ghana attain educational resources and create school programs that are inclusive to students with disabilities.

Ghana’s Limited Healthcare

The COVID-19 pandemic has decreased access to healthcare in Ghana, particularly for pregnant women seeking antenatal care. According to UNICEF, many pregnant women did not receive any antenatal care during the pandemic, either because it was unavailable or because they feared contracting COVID-19 at a health facility. Additionally, many children who were supposed to get standard vaccinations when the pandemic broke out did not receive them due to a vaccine shortage and fears of catching COVID-19 at health facilities.

The World Health Organization (WHO) is working with Ghana to make healthcare more accessible, ensuring health facilities are safe and have the resources they need. As the first country to receive the COVAX vaccine in February 2021, Ghana has been on the road to recovery from COVID-19 for several months. The country also received 350,000 doses of the AstraZeneca vaccine in May 2021. The Ghanaian government, UNICEF, Gavi and WHO are collaborating to endorse and distribute COVID-19 vaccines, which will help mitigate the impact of COVID-19 on poverty in Ghana.

Unemployment and Wage Reductions Skyrocket

According to the World Bank, more than 770,000 Ghanaian workers experienced wage reductions between March and June 2020 because of the pandemic and 42,000 workers experienced layoffs. While some businesses received support from the government, others did not or were unaware that such resources were available. Many businesses had to close at the beginning of the pandemic, which led to long-term financial struggles. The World Bank is working with the Ghanaian government to help businesses overcome damage from the pandemic and gain resilience in preparation for other economic changes. The organization is focused on raising awareness about government support programs like the Coronavirus Alleviation Programme, which protects jobs and benefits small businesses. The World Bank is also working on creating long-term, educational solutions that prepare young people in Ghana to enter the workforce with adaptability, certifications and a wide range of skill sets.

Solutions in the Works

Many organizations are working alongside the Ghanaian government to combat the impact of COVID-19 on poverty in Ghana. Organizations like UNICEF and Human Rights Watch are actively working to provide Ghana’s impoverished people with the resources needed to survive, including food, water, healthcare and education. The COVID-19 vaccine offers hope that Ghana will recover from the pandemic, opening the door for improvements in healthcare, education and jobs.

– Cleo Hudson
Photo: Unsplash

, , , , , ,

COVID-19 Vaccination in Uruguay

COVID-19 Vaccination in UruguayAt the start of the COVID-19 pandemic, Uruguay had some of the lowest infection rates in Latin America. On June 30, 2020, Bloomberg reported that while its bordering country Brazil had 1.34 million total cases, Uruguay had only 932 cases. Now, about a year later, COVID-19 vaccination rates in Uruguay are among the highest in Latin America, with more than four million doses received by citizens.

Impacts of COVID-19 in Uruguay

As a result of the COVID-19 pandemic, Uruguay’s unemployment rates have increased dramatically. In March 2020, more than 86,000 citizens applied for unemployment insurance. Before the pandemic, applications averaged 11,000 per month. A complete vaccination rollout is critical for Uruguay’s citizens to return to work.

Uruguay has already started to reopen businesses, but since only about half of the country has been vaccinated, infections are increasing. In order to avoid another shutdown of the country and another fall in employment, efforts for COVID-19 vaccination in Uruguay need to receive continued support and funding.

Vaccine Success

On June 8, 2021, Uruguay released reports about the success of the Sinovac Biotech vaccine along with more information about the Pfizer vaccine. According to Reuters, Sinovac’s COVID-19 vaccine was more than 90% successful in preventing intensive hospitalization and death. Further, the vaccine reduced COVID-19 infections by 61%. The Pfizer vaccine was 94% effective in preventing intensive care hospitalization and death and 78% effective in reducing COVID-19 infections.

Increasing COVID-19 Cases in Uruguay

COVID-19 vaccination in Uruguay has been very successful so far, with 52% of the population given at least one dose of either the Sinovac, Pfizer or AstraZeneca vaccines. Despite this success, Uruguay is also facing a crisis as COVID-19 infections skyrocket.

For several weeks in late May and early June 2021, Uruguay had one of the highest global COVID-19 related death rates per capita. In the last week of May 2021, the small nation of just 3.5 million residents recorded an average of 55 deaths per day. Many experts blame public health guidelines that have become increasingly lax as the pandemic continues. Not enough of the population is vaccinated to support the less restrictive public health measures and Uruguay is now rushing to further increase its vaccination rates.

Global Support

The United States is working with COVAX to improve the vaccine rollout around the world, which might help Uruguay. COVAX is led by the Coalition for Epidemic Preparedness Innovations, the World Health Organization, Gavi and UNICEF. Its goal is to vaccinate at least 20% of every participating country’s population by the end of 2021. NPR notes that it may not be able to meet this goal due to the global vaccine shortage. Wealthier countries that have already secured enough vaccines for their populations need to step in to help struggling countries with vaccine donations.

Supporting the Global Vaccine Rollout

According to the Stanford Social Innovation Review, there are many ways in which organizations can support the global vaccine rollout. First, it is important that there is a level of trust between citizens and the distributors of the vaccine. Many people are hesitant about vaccines because they do not necessarily trust the intentions of vaccine developers. With trustworthy messengers such as community leaders and trusted organizations working to combat vaccine hesitancy, people may be less reluctant to receive a vaccine.

Second, the delivery of vaccinations requires innovation. A major problem for those in rural and low-income areas is a lack of access. Many cannot travel far to receive a dose, therefore, investing in creative ways to deliver vaccines to remote locations is important. For example, implementing mobile vaccination sites.

Finally, supporting the training of local healthcare workers in contact tracing, COVID-19 education and vaccination means more people will be qualified to address the pandemic. Thus, COVID-19 vaccination in Uruguay can continue long after global organizations leave the area, ensuring efforts are sustainable. With private and public sector groups working together, combating the COVID-19 pandemic and improving global health is not a distant goal.

– Jessica Li
Photo: Flickr

, , , ,

The Impact of COVID-19 on Poverty in the DRC

COVID-19 and poverty in the Democratic Republic of Congo
The intersection of COVID-19 and poverty in the Democratic Republic of the Congo (DRC) has worsened health and economic crises. In 2019, after years of political dissent, Félix Tshisekedi became president of the DRC. Prior to 2019, the nation had faced human rights violations as the previous president, Joseph Kabila, delayed elections and violently squandered peaceful protests to maintain his power beyond the constitutional two-term limit. Kabila killed hundreds of civilians in his quest to stay in power. Rebel groups have also displaced citizens and targeted healthcare workers for decades. Because of those groups and a new and fragile government, the DRC was particularly vulnerable to both COVID-19 and high poverty rates. Here is some information about the impact of COVID-19 on poverty in the DRC.

COVID-19 and Poverty in the DRC

When the coronavirus first appeared in the DRC, restrictions provided hope that conflicts would pause in the name of public health. However, rather than being able to safely receive necessary medical attention, persisting conflicts displaced at least 300,000 Congolese in Ituri Province. The mass displacement of Congolese made social distancing guidelines difficult to uphold, increasing individuals’ susceptibility to the virus. As of July 2021, the World Health Organization (WHO) reported there have been 43,333 confirmed coronavirus cases and 973 deaths in the DRC since January 2020.

The pandemic reinforced the link between poverty and disease in the DRC. The DRC has the third-largest population of people in poverty globally – an estimated 73% of Congolese lived on less than $1.90 per day in 2018. Furthermore, particularly high numbers of people in the eastern part of the country are battling preexisting conditions ranging from diabetes and high blood pressure to Ebola, putting them at an elevated risk of contracting COVID-19. In a study of 766 COVID-19 cases in the DRC, only 2.6% of patients with mild or moderate health conditions died from the virus, compared with 45% of patients with a severe condition. The DRC’s struggle against other public health issues exacerbates the threat of COVID-19, especially among those living in poverty.

Economic Growth During COVID-19 Pandemic

In addition to the threat of increased COVID-19 cases and deaths, the impact of COVID-19 on poverty in the DRC has thus far been drastic. In 2020, the unemployment rate reached 4.6%, a 10.17% jump from the previous year. As of October 2020, expectations determined that COVID-19 would push approximately 4 million people into poverty by the end of that year.

The DRC’s rate of economic growth fell from 4.4% before the pandemic to 0.8% in 2020. The contribution of extractive industries such as mining to the DRC’s economic growth fell from 0.28% in 2019 to 0.17% in 2020. Attempts to contain the virus via government restrictions also impacted the manufacturing and commerce sectors. According to the African Development Bank Group, non-extractive sectors’ contribution to economic growth fell from 4.1% in 2019 to -1.9% in 2020. However, recent analyses are pointing toward a relatively quick recovery in 2021 and 2022.

Vaccine Rollout in the DRC

Vaccine rollouts are increasing globally, a trend that predictions have determined could continue. At the G7 Summit in 2021, the United States shared its plan to donate 19 million vaccine doses to the WHO initiative COVAX, which will distribute them to low- and middle-income countries. In March 2021, the DRC received 1.7 million Oxford-AstraZeneca doses from COVAX, but returned them due to potential health concerns. Around the same time, many European countries had also suspended the rollout of the AstraZeneca vaccine because of possible blood clots. In early July, the health minister of the DRC reported the country was in its third wave of COVID-19. Donating new vaccine doses to the DRC is vital.

Community Efforts to Increase Vaccination Rates

Even with vaccines available, Congolese must elect to receive them. Bélle-Surprise Makaya, a health worker native to North Kivu, advocates for vaccines in local communities. She and colleagues initiated their campaign in April 2021, when the first shipment of Oxford-AstraZeneca vaccines arrived in the DRC.

Makaya recognizes many Congolese people’s anxiety about receiving the “jab.” She told Gavi, an organization that works to provide immunizations to low-income countries, that she is “committed to dispelling such hesitations.” Makaya notes that her coalition has led to higher turnout among local populations and not just healthcare workers.

The impact of COVID-19 on poverty in the DRC has been drastic. However, initiatives like COVAX are providing vaccines, and Congolese people are learning why they should receive the vaccine. More vaccinations will not only slow the spread of the virus, but will also aid economic recovery as the country will spend less money on public health. Economic recovery is undoubtedly on the horizon in the DRC as long as vaccine rollout continues.

– Krystal Koski
Photo: Flickr

, , , , ,

The Immunization Agenda 2030

Immunization AgendaAs the 18-month mark of COVID-19 nears, people around the world are eager to return to normalcy. However, according to The New York Times, as of March 2021, more than 75% of all vaccine doses have gone to the wealthiest countries. Meanwhile, organizations are committed to fighting for vaccine equity so that lower-income nations are not overlooked in global vaccination plans for any diseases. The World Health Organization, UNICEF and Gavi, among other partners, launched the Immunization Agenda 2030 on April 26, 2021. The Agenda aims to “maximize the lifesaving impact of vaccines through stronger immunization systems.” This includes securing vaccines for developing countries.

Global Vaccine Action Plan (GVAP)

Prior to the Immunization Agenda, there was the Global Vaccine Action Plan, spanning from 2011-2020. The ultimate goals of GVAP were providing universal vaccination access and “reducing vaccine-preventable diseases.” Under GVAP, poliovirus types two and three were eradicated and measles incidents decreased by more than 80%. GVAP did not meet all of the goals it intended to, however, it did succeed in laying out a steady framework to proceed with the Immunization Agenda 2030.

The Immunization Agenda 2030 focuses on global participation in improving global vaccine access to reduce the threat of preventable diseases and ensure vaccine equity This requires strengthening healthcare and immunization systems and increasing accessibility. The strategy has primary targets to achieve the goal of saving more than 50 million lives through vaccines.

Targets for 2030

  • Reach at least 90% coverage of core childhood and adolescent vaccines
  • Reduce by 50% the number of children who go entirely unvaccinated
  • “Complete 500 national or subnational introductions of new or under-utilized vaccines — such as those for COVID-19, rotavirus or human papillomavirus (HPV)”

Immunization for Global Development

Since “immunization is the foundation of a healthy, productive population” vaccines contribute to global development. Children who are in full health have better chances of educational success, which contributes to economic prosperity and reduces poverty. Furthermore, preventing diseases means easing the burden on healthcare systems throughout the world.

The Agenda hopes to completely eliminate yellow fever outbreaks by 2026 and “reduce viral hepatitis B deaths by 65% by 2030.” According to the WHO, 47 countries across Africa and Central and South America are most burdened with yellow fever. In 2013 alone, yellow fever is estimated to have killed up to 60,000 people. Additionally, Africa has the highest cases of viral hepatitis in the world. According to WHO global data, in 2015, almost 260 million people had hepatitis B. As these diseases are less prevalent in wealthier countries, the Immunization Agenda calls for accountability to ensure high-income nations are doing their part for global immunizations.

Challenges

Achieving universal vaccine coverage comes with its own challenges. Vaccine hesitancy poses a threat to immunization. Founding partners of the Agenda place an emphasis on the trustworthy spread of information and an increase in health literacy to ensure vaccinations become a social norm. Additionally, the present threat of climate change greatly increases the risk of future pandemics and the spread of infectious diseases, especially via mosquitoes. The Agenda itself is working to limit the “environmental impact of vaccine waste.”

Moving Forward

The Immunization Agenda provides reachable goals to greatly reduce preventable disease deaths. The Agenda is calling for leaders in global health to make their commitments to the Agenda explicit. It also encourages leaders to urgently invest in strengthening their health systems, especially in the wake of COVID-19. The Agenda prompts leading governments and scientists to invest more time into vaccine research and development to strengthen the impact of vaccines and combat global diseases more effectively. Vaccines are the foundation of global health security and the Immunization Agenda 2030 commits to achieving vaccine equity and ensuring vaccines reach the people who need them most.

– Monica Mellon
Photo: Flickr